Feature Article
Cardiac-specific overexpression of Gαq alters excitation–contraction coupling in isolated cardiac myocytes

https://doi.org/10.1006/jmcc.1999.0966Get rights and content

Abstract

Transgenic mice with cardiac-specific overexpression of Gαq exhibit a biochemical and physiological phenotype of load-independent cardiac hypertrophy with contractile dysfunction. To elucidate the cellular basis for altered contractility, we measured cellular contraction, Ca2+transients, andl-type Ca2+channel currents (ICa) in left ventricular (LV) myocytes isolated from non transgenic (NT) controls or Gαq hearts. Although baseline contractile function (% shortening) and the amplitude of Ca2+transients in Gαq myocytes were similar to NT myocytes, the rates of cellular shortening and relengthening and the duration of Ca2+transients were prolonged in Gαq myocytes. Myocytes from Gαq hearts had larger cell capacitance but no change in ICadensity, voltage-dependence of activation and inactivation. The responses of ICato dihydropyridine drugs and a membrane permeable cAMP analog, 8-(4-chlorophenylthio) cAMP, were not altered; however, the time course of ICainactivation was significantly slower in Gαq myocytes compared to NT myocytes. The kinetic difference in inactivation was abolished when Ba2+was used as the charge carrier or when the sarcoplasmic reticulum (SR) Ca2+was depleted by ryanodine, suggesting that Ca2+-dependent inactivation is reduced in Gαq myocytes due to altered SR Ca2+release. Consistent with this hypothesis, the function of SR as assessed by the maximal Ca2+uptake rates and the apparent affinity of SR Ca2+-ATPase for Ca2+was reduced in ventricles of Gαq heart. These results suggest that the reduced SR function contributes to the depressed contractility associated with this form of cardiac hypertrophy.

References (0)

Cited by (35)

  • The atypical 'b' splice variant of phospholipase Cβ1 promotes cardiac contractile dysfunction

    2015, Journal of Molecular and Cellular Cardiology
    Citation Excerpt :

    Conditional overexpression in adult hearts of GαqQ209L, like Gαq-WT, does not result in hypertrophy, but instead initiates a rapid loss of contractility, along with chamber dilatation and subsequent heart failure [43]. The reduced contractility, associated with depressed SR Ca2 + cycling [44] is reminiscent of responses to PLCβ1b, although the phenotype is more complex and more severe following conditional expression of GαqQ029L. Significantly, all of these responses to GαqQ209L appeared to require PLCβ activation, because a GαqQ209L mutant unable to activate PLCβ subtypes (GαqQ209LAA) did not cause any of these changes.

  • Down regulation of the L-type Ca<sup>2+</sup> channel, GRK2, and phosphorylated phospholamban: protective mechanisms for the denervated failing heart

    2006, Journal of Molecular and Cellular Cardiology
    Citation Excerpt :

    Myocardial cells were filtered through a 200 μm nylon mesh and stored in Krebs–Henseleit solution containing 1 mmol/l Ca2+. Myocyte contraction and relaxation functions were measured using a video motion edge detector at 32 °C, as previously described in [30,31]. Whole-cell ICa were characterized using patch-clamp techniques at room temperature (22–23 °C), as previously described in [32,33].

  • Mechanism of Enhanced Cardiac Function in Mice with Hypertrophy Induced by Overexpressed Akt

    2003, Journal of Biological Chemistry
    Citation Excerpt :

    The inactivation kinetics of ICa at +10 mV was significantly faster in TG myocytes compared with WT myocytes (Fig. 2B). In mouse ventricular myocytes, ICa inactivation is controlled by Ca2+ in the sarcolemmal subspace (19, 23, 24). To examine whether the difference in ICa inactivation rate between WT and TG myocytes was due to the contribution of Ca2+ released from the SR, the SR Ca2+ content was depleted by ryanodine (10 μm).

  • Ventricular remodeling in heart failure

    2002, Journal of Cardiac Failure
View all citing articles on Scopus
f1

Please address all correspondence to: Dr Atsuko Yatani, Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0575. E-mail: [email protected]

View full text